CPAD - Critical Path for Alzheimer`s Disease

OBD becomes a member of the CPAD Initiative. This consortium works with industry, regulatory authorities, and patient advocacy organisations to advance Drug Development Tools (DDTs) for evaluating drug efficacy and safety.